Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy
Clinical trial NCT00005779 · COMPLETED
Trial details
- NCT number
- NCT00005779
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.